205 related articles for article (PubMed ID: 8881452)
1. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
[TBL] [Abstract][Full Text] [Related]
3. A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer.
Cetani F; Pardi E; Viacava P; Pollina GD; Fanelli G; Picone A; Borsari S; Gazzerro E; Miccoli P; Berti P; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2004 Jan; 60(1):99-106. PubMed ID: 14678295
[TBL] [Abstract][Full Text] [Related]
4. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma.
Shattuck TM; Kim TS; Costa J; Yandell DW; Imanishi Y; Palanisamy N; Gaz RD; Shoback D; Clark OH; Monchik JM; Wierman ME; Hollenberg A; Tojo K; Chaganti RS; Arnold A
Clin Endocrinol (Oxf); 2003 Aug; 59(2):180-9. PubMed ID: 12864795
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
Br J Cancer; 1996 Nov; 74(10):1615-9. PubMed ID: 8932343
[TBL] [Abstract][Full Text] [Related]
6. Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36.
Williamson C; Pannett AA; Pang JT; Wooding C; McCarthy M; Sheppard MN; Monson J; Clayton RN; Thakker RV
J Med Genet; 1997 Aug; 34(8):617-9. PubMed ID: 9279750
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
Pei L; Melmed S; Scheithauer B; Kovacs K; Benedict WF; Prager D
Cancer Res; 1995 Apr; 55(8):1613-6. PubMed ID: 7712461
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):523-8. PubMed ID: 9425391
[TBL] [Abstract][Full Text] [Related]
9. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
10. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
Kerangueven F; Allione F; Noguchi T; Adélaïde J; Sobol H; Jacquemier J; Birnbaum D
Genes Chromosomes Cancer; 1995 Aug; 13(4):291-4. PubMed ID: 7547638
[TBL] [Abstract][Full Text] [Related]
11. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
[TBL] [Abstract][Full Text] [Related]
13. Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features.
Yoshimoto K; Endo H; Tsuyuguchi M; Tanaka C; Kimura T; Iwahana H; Kato G; Sano T; Itakura M
Clin Endocrinol (Oxf); 1998 Jan; 48(1):67-72. PubMed ID: 9509070
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
[TBL] [Abstract][Full Text] [Related]
17. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
